FDA Inspection 1085178 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Mar 8, 2019 in Orange Park, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 8, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Orange Park, FL (United States)